-+ 0.00%
-+ 0.00%
-+ 0.00%

UROGEN’S FINAL RESULTS FROM OLYMPUS FIVE-YEAR FOLLOW-UP STUDY REINFORCES DURABLE RESPONSE WITH JELMYTO IN PATIENTS WITH LOW-GRADE UPPER TRACT UROTHELIAL CANCER

Reuters·10/28/2026 12:00:04

Please log in to view news